View the file

Other files for this federal contract opportunity

Other files attached to Ingenuity Pathway Analysis – IPA Analysis Match Explorer CL – Software, newest first.
File Type Posted
D_FAR 52.212-5 (Mar 2023).pdf PDF
D_FAR 52.204-26 Oct 2020.pdf PDF
D_FAR 52.204-24 Nov 2021.pdf PDF
D_Invoicing Instructions With IPP 3-23.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

1. Statement of Need and Purpose: Ingenuity Pathway Analysis – one institute-wide floating annual license – IPA Analysis Match Explorer CL – Qiagen Software.

2. Background Information and Objective: Aging and age-related diseases are caused by complex interplay of many different factors. To better understand the cause-effect relationship, the finding of high-throughput assays such as RNA sequencing or microarray needs to be looked at in the context of biological processes and pathways.

The Ingenuity Pathway Analysis software is an all-in-one, web-based software application that enables researchers to analyze, integrate, and understand data derived from gene expression, microRNA, and SNP microarrays; phosphoproteomics, metabolomics, proteomics, and RNA-Seq experiments; and small-scale experiments that generate gene and chemical lists. The IPA software will help the researchers to look at altered biological processes and pathways.

3. Generic Name of Product: Ingenuity Pathway Analysis - IPA Analysis Match Explorer CL

4. Purchase Description:

Product Name Product Code Quantity Term (months) Start Date End Date

IPA Analysis Match Explorer CL 836506 1 12.00 May 17, 2023 May 16, 2024

5. Salient characteristics: IPA is an all-in-one, web-based software application that enables researchers to analyze, integrate, and understand data derived from gene expression, microRNA, and SNP microarrays; phosphoproteomics, metabolomics, proteomics, and RNA-Seq experiments; and small-scale experiments that generate gene and chemical lists.

6. Quantity: 1 license

7. Delivery Date: N/A

8. Period of Performance: May 17, 2023-May 16, 2024 (base)

9. Option(s): May 17, 2024-May 16, 2025 (Option Period One) May 17, 2025-May 16, 2026 (Option Period Two)

File details come from the government source that posted it. Updated .